You are here

Clinical Trials: Cord Blood

Comment

Discuss
Conditions:   B-Lymphoid Malignancies;   Acute Lymphocytic Leukemia;   Chronic Lymphocytic Leukemia;   Non-hodgkin Lymphoma
Interventions:   Drug: Fludarabine;   Drug: Cyclophosphamide;   Drug: Mesna;   Biological: iC9/CAR.19/IL15-Transduced CB-NK Cells;   Drug: AP1903
Sponsors:   M.D. Anderson Cancer Center;   Bellicum Pharmaceuticals
Not yet recruiting - verified April 2017
Condition:   B-Cell Non-Hodgkin Lymphoma
Interventions:   Biological: NK Cells;   Drug: Rituximab;   Drug: Carmustine;   Drug: Etoposide;   Drug: Cytarabine;   Drug: Melphalan;   Drug: Lenalidomide 10Mg Capsule;   Drug: G-CSF;   Biological: Auto SCT;   Other: Apheresis
Sponsor:   M.D. Anderson Cancer Center
Not yet recruiting - verified March 2017
Conditions:   Acute Leukemia;   Immune Deficiency Disorder;   Congenital Hematological Disorder;   Metabolism Disorder;   Aplastic Anemia;   Myelodysplastic Syndromes;   Chronic Leukemia;   Lymphoma;   Multiple Myeloma;   Solid Tumor
Interventions:   Radiation: Total Body Irradiation 1200 cGy;   Radiation: Total Body Irradiation 200 cGy;   Drug: Cyclophosphamide;   Drug: Mesna;   Procedure: Cord Blood Infusion;   Drug: Busulfan;   Drug: Fludarabine;   Drug: Melphalan
Sponsor:   University of Rochester
Recruiting
Conditions:   Alpha Thalassemia Major;   Hemoglobinopathy; With Thalassemia;   Hemoglobinopathies;   Fetal Anemia;   Fetal Hydrops;   Alpha; Thalassemia;   Thalassemia Major;   Thalassemia Alpha;   A-Thalassemia
Intervention:   Biological: in utero hematopoietic stem cell transplantation
Sponsor:   University of California, San Francisco
Recruiting
Conditions:   Stroke;   Stroke, Acute;   Brain Injury, Acute
Interventions:   Biological: Umbilical Cord Blood;   Other: Placebo
Sponsors:   Joanne Kurtzberg, MD;   The Marcus Foundation;   Emory University;   M.D. Anderson Cancer Center
Recruiting - verified March 2017
Condition:   Severe Aplastic Anemia
Interventions:   Drug: Antithymocyte Globulin;   Drug: Fludarabine;   Drug: Cyclophosphamide;   Radiation: Total Body Irradiation (TBI);   Procedure: UCB HSCT;   Procedure: Haplo HSCT;   Drug: Tacrolimus;   Drug: Mycophenolate mofetil (MMF);   Drug: G-CSF
Sponsors:   Medical College of Wisconsin;   National Heart, Lung, and Blood Institute (NHLBI);   National Cancer Institute (NCI);   Blood and Marrow Transplant Clinical Trials Network;   National Marrow Donor Program
Recruiting - verified August 2017
Condition:   Cell Transplantation
Interventions:   Drug: Pneumostem;   Drug: Normal saline
Sponsor:   Samsung Medical Center
Recruiting - verified April 2017
Condition:   Deficiency of Anterior Cruciate Ligament
Interventions:   Biological: Cartistem(TM);   Biological: hyaluronic acid;   Procedure: ACL reconstruction only
Sponsor:   Samsung Medical Center
Completed
Conditions:   Leukemia;   Lymphoma;   Myeloma;   Myeloproliferative Diseases
Interventions:   Drug: Busulfan;   Drug: Fludarabine;   Drug: Clofarabine;   Drug: Rabbit ATG;   Radiation: Total Body Irradiation (TBI);   Procedure: Cord Blood Infusions;   Drug: Rituximab;   Drug: Cyclophosphamide;   Procedure: Natural Killer Cell Infusion;   Drug: Melphalan;   Drug: Mesna
Sponsors:   M.D. Anderson Cancer Center;   National Cancer Institute (NCI);   Cancer Prevention Research Institute of Texas
Recruiting

Pages